Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03258931 |
|---|---|
| Brief Title: | Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML |
| First Submitted : | August 21, 2017 |
| First Submitted that Met QC Criteria : | August 21, 2017 |
| First Posted : | August 23, 2017 |
| Last Update Submitted that Met QC Criteria : | May 21, 2020 |
| Last Update Posted : | May 22, 2020 |